We are live on ! Find out more
GEA

Glen Eagle Advisors Portfolio holdings

AUM $714M
1-Year Est. Return 18.87%
This Fund
S&P 500
This Quarter Est. Return
+11.03%
1 Year Est. Return
+18.87%
3 Year Est. Return
+62.99%
5 Year Est. Return
+76.32%
10 Year Est. Return
AUM
$254M
AUM Growth
+$31M
Cap. Flow
+$8.11M
Cap. Flow %
3.19%
Top 10 Hldgs %
33.81%
Holding
1,016
New
101
Increased
218
Reduced
172
Closed
42

Sector Composition

Rank Sector Weight
1 Technology 12.03%
2 Healthcare 11.53%
3 Financials 5.44%
4 Consumer Discretionary 4.95%
5 Communication Services 4.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICE icon
901
Intercontinental Exchange
ICE
$82.4B
$1.15K ﹤0.01%
10
MUSA icon
902
Murphy USA
MUSA
$11.3B
$1.09K ﹤0.01%
8
ASIX icon
903
AdvanSix
ASIX
$567M
$1.08K ﹤0.01%
54
-7
-11% -$120
EHTH icon
904
eHealth
EHTH
$42.5M
$1.06K ﹤0.01%
15
FCBC icon
905
First Community Bankshares
FCBC
$915M
$1.01K ﹤0.01%
47
CAMP
906
DELISTED
CalAmp Corp.
CAMP
$992 ﹤0.01%
4
ALC icon
907
Alcon
ALC
$33.1B
$990 ﹤0.01%
15
OPK icon
908
Opko Health
OPK
$921M
$988 ﹤0.01%
250
CMS icon
909
CMS Energy
CMS
$23.1B
$976 ﹤0.01%
16
OXY.WS icon
910
Occidental Petroleum Corp Warrants
OXY.WS
$33.2B
$967 ﹤0.01%
142
-21
-13% -$95
OSK icon
911
Oshkosh
OSK
$9.67B
$947 ﹤0.01%
+11
New +$875
AHCO icon
912
AdaptHealth
AHCO
$1.46B
$939 ﹤0.01%
+25
New +$773
W icon
913
Wayfair
W
$11.1B
$903 ﹤0.01%
4
CRDF icon
914
Cardiff Oncology
CRDF
$64.3M
$900 ﹤0.01%
50
+45
+900% +$791
LCTX icon
915
Lineage Cell Therapeutics
LCTX
$257M
$880 ﹤0.01%
500
IQ icon
916
iQIYI
IQ
$1.18B
$874 ﹤0.01%
+50
New +$1.13K
NXST icon
917
Nexstar Media Group
NXST
$5.6B
$874 ﹤0.01%
8
VNTR
918
DELISTED
Venator Materials PLC
VNTR
$828 ﹤0.01%
250
RLMD icon
919
Relmada Therapeutics
RLMD
$544M
$802 ﹤0.01%
25
AVNS icon
920
Avanos Medical
AVNS
$1.17B
$780 ﹤0.01%
17
EMLC icon
921
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.74B
$765 ﹤0.01%
23
AIG icon
922
American International
AIG
$41.9B
$757 ﹤0.01%
20
KGC icon
923
Kinross Gold
KGC
$28.5B
$741 ﹤0.01%
+101
New +$805
BHF icon
924
Brighthouse Financial
BHF
$3.63B
$724 ﹤0.01%
20
+14
+233% +$470
VYGR icon
925
Voyager Therapeutics
VYGR
$187M
$715 ﹤0.01%
100

Similar funds

Glen Eagle Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Glen Eagle Advisors held 1,016 positions worth $254M, up 14% from $223M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Glen Eagle Advisors deployed $8.11M of net new capital in Q4 2020, opening 101 new positions and adding to 218 existing holdings. Its largest new stake was First Trust Smith Opportunistic Fixed Income ETF: 1,950 shares worth $107K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Amazon, an estimated $466K trimmed.

  • Glen Eagle Advisors's largest Q4 2020 buy was First Trust Smith Opportunistic Fixed Income ETF: 1,950 shares worth $107K.
  • Glen Eagle Advisors added most to iShares AAA-A Rated Corporate Bond ETF in Q4 2020, an estimated $2.12M increase.
  • Glen Eagle Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $466K.
  • Glen Eagle Advisors fully exited Invesco BulletShares 2020 Corporate Bond ETF in Q4 2020, selling an estimated $514K.
  • Glen Eagle Advisors's ten largest holdings make up 34% of its $254M portfolio in Q4 2020.
  • Glen Eagle Advisors opened 101 new positions and closed 42 in Q4 2020.
  • Glen Eagle Advisors's portfolio value rose 14% quarter-over-quarter to $254M.

Based on Glen Eagle Advisors's 13F filing for Q4 2020, filed 13 Aug 2024.